Javascript must be enabled to continue!
Tenofovir Overdosage-A Rarely Reported Phenomenon in Literature
View through CrossRef
Introduction: Hepatitis B virus (HBV) has infected affected thirty three percent of the world population, two
billion have been infected worldwide and out of them, 350 million suffer from chronic HBV infection. Out of
these, approximately 15–40% of patients will develop cirrhosis, liver failure and hepatocellular carcinoma. The
most common side effects of tenofovir are nausea, vomiting, diarrhea, bloating, flatulence, indigestion, loss of
appetite, headache, weakness (asthenia), dizziness, insomnia, rash, itching, back pain, pain, renal failure, lactic
acidosis, alopecia and osteoporosis. There is paucity of research regarding overdosage of tenofovir. Hence, the
need of this case report.
Case Report: We are reporting a thirty-year-old male of chronic hepatitis B who was in active phase thus was
put on Tenofovir disoproxil fumarate (TDF) 300 mg daily once. The six -month therapy was issued to him free
of cost under National viral hepatitis control program (NVHCP). As the six bottles of tenofovir were of different
time period of expiry, hence they were numbered from 1-6, for ease of patient, so that number 1 bottle is
finished first and number 6 was to be taken in last. It was clearly explained to him that only one tablet has to be
taken in a day. There were no accompanying family members at the time of dispensing of drugs. The patient
reported after one month with complaints of irritability, vertigo, restlessness, red eyes, feeling of radiation of
heat from body and headache. We have never seen these kinds of side effects with tenofovir in 2500 patients in
last 13 years who are on regular treatment and follow-up. There was no history of any kind of drug intake with
tenofovir, alteration in food habits, any kind of drug or alcohol abuse in last one month when tenofovir was
started. On probing further, he admitted that he was taking six tablets of tenofovir per day. The reason given was
that by mistake on reading number 6 written on one bottle, he understood that six tablets per day are to be taken
in a day. The reality is that number 6 was written on that particular bottle for depicting that this bottle has to be
used in last i.e. in sixth month. The patient all biochemical labs including liver function & renal function, blood
sugar, thyroid profile, serum electrolytes, serum calcium and phosphorus levels, urine complete examination,
ECG, chest x-ray and ultrasonogram abdomen was essentially normal. He was immediately shifted on daily
once dosage of tenofovir. All his symptoms subsided within a week.
Conclusion: Every drug has well documented side effects but it is not necessary that manifestations due to
overdosage are available for all the available drugs. Similarly, there is scarcity of data regarding overdose of
tenofovir which occurred in our case. The relieving side was that patient did not develop life threatening
complications like lactic acidosis and renal failure. Our case report re-affirms the need of repeatedly explaining
to the patients about proper dosage of drugs.
Title: Tenofovir Overdosage-A Rarely Reported Phenomenon in Literature
Description:
Introduction: Hepatitis B virus (HBV) has infected affected thirty three percent of the world population, two
billion have been infected worldwide and out of them, 350 million suffer from chronic HBV infection.
Out of
these, approximately 15–40% of patients will develop cirrhosis, liver failure and hepatocellular carcinoma.
The
most common side effects of tenofovir are nausea, vomiting, diarrhea, bloating, flatulence, indigestion, loss of
appetite, headache, weakness (asthenia), dizziness, insomnia, rash, itching, back pain, pain, renal failure, lactic
acidosis, alopecia and osteoporosis.
There is paucity of research regarding overdosage of tenofovir.
Hence, the
need of this case report.
Case Report: We are reporting a thirty-year-old male of chronic hepatitis B who was in active phase thus was
put on Tenofovir disoproxil fumarate (TDF) 300 mg daily once.
The six -month therapy was issued to him free
of cost under National viral hepatitis control program (NVHCP).
As the six bottles of tenofovir were of different
time period of expiry, hence they were numbered from 1-6, for ease of patient, so that number 1 bottle is
finished first and number 6 was to be taken in last.
It was clearly explained to him that only one tablet has to be
taken in a day.
There were no accompanying family members at the time of dispensing of drugs.
The patient
reported after one month with complaints of irritability, vertigo, restlessness, red eyes, feeling of radiation of
heat from body and headache.
We have never seen these kinds of side effects with tenofovir in 2500 patients in
last 13 years who are on regular treatment and follow-up.
There was no history of any kind of drug intake with
tenofovir, alteration in food habits, any kind of drug or alcohol abuse in last one month when tenofovir was
started.
On probing further, he admitted that he was taking six tablets of tenofovir per day.
The reason given was
that by mistake on reading number 6 written on one bottle, he understood that six tablets per day are to be taken
in a day.
The reality is that number 6 was written on that particular bottle for depicting that this bottle has to be
used in last i.
e.
in sixth month.
The patient all biochemical labs including liver function & renal function, blood
sugar, thyroid profile, serum electrolytes, serum calcium and phosphorus levels, urine complete examination,
ECG, chest x-ray and ultrasonogram abdomen was essentially normal.
He was immediately shifted on daily
once dosage of tenofovir.
All his symptoms subsided within a week.
Conclusion: Every drug has well documented side effects but it is not necessary that manifestations due to
overdosage are available for all the available drugs.
Similarly, there is scarcity of data regarding overdose of
tenofovir which occurred in our case.
The relieving side was that patient did not develop life threatening
complications like lactic acidosis and renal failure.
Our case report re-affirms the need of repeatedly explaining
to the patients about proper dosage of drugs.
Related Results
Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients
Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients
Background:
Tenofovir disoproxil fumarate is a prodrug of tenofovir diphosphate that
exposes patients to renal toxicity over the long term. Tenofovir alafenamide, a new prodrug, no...
Pharmacokinetic Study of Tenofovir Disoproxil Fumarate Combined with Rifampin in Healthy Volunteers
Pharmacokinetic Study of Tenofovir Disoproxil Fumarate Combined with Rifampin in Healthy Volunteers
ABSTRACT
Tenofovir disoproxil fumarate (tenofovir DF) was studied in combination with rifampin in 24 healthy subjects in a multiple-dose, open-label, single-...
Switching to Tenofovir Therapy Versus Continuation of Entecavir for Patients With Hepatitis B Virus Infection: A Systematic Review and Meta‐Analysis
Switching to Tenofovir Therapy Versus Continuation of Entecavir for Patients With Hepatitis B Virus Infection: A Systematic Review and Meta‐Analysis
ABSTRACTBackgroundHepatitis B virus (HBV) infection causes liver disease, including hepatocellular carcinoma. Controlling viral activity is crucial to reducing complications. Tenof...
Pharmacokinetic interaction between TMC114/ritonavir and tenofovir disoproxil fumarate in healthy volunteers
Pharmacokinetic interaction between TMC114/ritonavir and tenofovir disoproxil fumarate in healthy volunteers
What is already known about this subject • Tenofovir disoproxil fumarate and some of the HIV protease inhibitors show drug–drug interactions that cannot be predicted based on their...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Female Genital Tract Host Factors and Tenofovir and Lamivudine Active Metabolites
Female Genital Tract Host Factors and Tenofovir and Lamivudine Active Metabolites
Abstract
Background
We previously reported the effect of contraception on cervical tenofovir concentrations in Ugandan women wit...
Primerjalna književnost na prelomu tisočletja
Primerjalna književnost na prelomu tisočletja
In a comprehensive and at times critical manner, this volume seeks to shed light on the development of events in Western (i.e., European and North American) comparative literature ...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...

